SEC 13F Intelligence

Palo Alto Investors LP / ABMDEUR

Palo Alto Investors LP’s Abiomed Inc Position

Does Palo Alto Investors LP own Abiomed Inc (ABMDEUR)? Not currently — the last reported position was 490.8K shares worth $121M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$121M
Q3 2022
Shares
490.8K
% of Portfolio
+9.53%
Quarters Held
16
position exited

Position History ABMDEUR

Reported value by quarter
Q4 ’18: $224MQ4 ’18Q1 ’19: $200MQ2 ’19: $184MQ2 ’19Q3 ’19: $116MQ4 ’19: $96MQ4 ’19Q1 ’20: $73MQ2 ’20: $119MQ2 ’20Q3 ’20: $140MQ4 ’20: $180MQ4 ’20Q1 ’21: $183MQ2 ’21: $182MQ2 ’21Q3 ’21: $179MQ4 ’21: $186MQ4 ’21Q1 ’22: $164MQ2 ’22: $122MQ2 ’22Q3 ’22: $121Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2022490.8K$121M+9.53%
Q2 2022494.4K$122M+10.67%
Q1 2022494.4K$164M+12.66%
Q4 2021519.0K$186M+11.91%
Q3 2021549.8K$179M+10.80%
Q2 2021583.9K$182M+10.04%
Q1 2021575.2K$183M+10.45%
Q4 2020556.6K$180M+9.46%
Q3 2020504.0K$140M+7.66%
Q2 2020492.3K$119M+7.14%
Q1 2020502.7K$73M+6.11%
Q4 2019564.2K$96M+5.30%
Q3 2019654.4K$116M+7.75%
Q2 2019706.4K$184M+8.95%
Q1 2019698.7K$200M+8.32%
Q4 2018689.5K$224M+11.93%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Palo Alto Investors LP’s full portfolio or all institutional holders of ABMDEUR.